Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Second-generation proximally coated titanium femoral component: minimum 7-year results.

It is unclear whether resurfacing or fully porous-coated or proximally coated stems are the best femoral components for young patients. First-generation proximally coated titanium fiber-metal femoral components had a high rate of failure. We prospectively followed 56 patients (70 hips) whom we believed were at high risk for loosening of a cemented femoral component; all patients were implanted with one second-generation proximally coated titanium femoral component. Ten patients (11 hips) died and three patients (four hips) were lost to minimum followup. Three models of titanium fiber-metal acetabular component were implanted with screws. Patients were clinically evaluated using the Harris hip score. We used standardized radiographs to assess fixation status and osteolysis. Forty-four patients (55 hips) with a mean age of 45 years were followed for a minimum of 7 years (mean, 10.5 years; range, 7-15 years). No femoral component had been revised for any reason. Bone ingrowth (spot welding) was seen in 41 hips (75%) and proximal femoral osteolysis in only four hips. Reoperations for polyethylene wear were performed in seven patients (12.7%) and two patients had liner exchange for recurrent dislocation. Even with an articulating surface with considerable polyethylene wear debris, these second-generation proximally coated titanium fiber-metal femoral components had a survival rate of 100% at a mean 10.5-year followup.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app